These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18629573)

  • 1. Systematic review of trends in prophylaxis of corticosteroid-induced osteoporosis: the need for standard audit guidelines.
    Duyvendak M; Naunton M; van Roon EN; Bruyn GA; Brouwers JR
    Osteoporos Int; 2008 Oct; 19(10):1379-94. PubMed ID: 18629573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Glucocorticoid-Induced Osteoporosis: Clinical audit to evaluate the implementation of National Osteoporosis Guideline Group 2017 guidelines in a primary care setting.
    Carter M
    J Clin Densitom; 2019; 22(1):25-30. PubMed ID: 29729949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doctors' beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention.
    Duyvendak M; Naunton M; van Roon EN; Brouwers JR
    J Clin Pharm Ther; 2011 Jun; 36(3):356-66. PubMed ID: 21545615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
    Gera C; Vij AS
    Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands.
    Erb N; Duncan RC; Raza K; Rowe IF; Kitas GD; Situnayake RD;
    Rheumatology (Oxford); 2002 Sep; 41(9):1021-4. PubMed ID: 12209036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in The Netherlands 2001-2005.
    Duyvendak M; Naunton M; Atthobari J; van den Berg PB; Brouwers JR
    Osteoporos Int; 2007 Oct; 18(10):1429-33. PubMed ID: 17323108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of osteoporosis in glucocorticoid-treated neurology patients.
    Lozsadi DA; Peters G; Sadik HY; Kellett MW; Fox SH; Smith DF
    Clin Neurol Neurosurg; 2006 Feb; 108(2):157-62. PubMed ID: 16303241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline Promotion Increases Prescription of Bone Protection with Steroids in Hospitalised Patients.
    Harty L; Clare J; Finnerty D; van der Kamp S; Kennedy F; Callanan I; McKenna MJ; FitzGerald O
    Ir Med J; 2015; 108(7):216-7. PubMed ID: 26349354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.
    Bell JM; Shields MD; Watters J; Hamilton A; Beringer T; Elliott M; Quinlivan R; Tirupathi S; Blackwood B
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010899. PubMed ID: 28117876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E; Walker-Bone K
    QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the increase in osteoporosis prevention a result of the audit?
    Naunton M
    Clin Neurol Neurosurg; 2006 Oct; 108(7):718-9. PubMed ID: 16621242
    [No Abstract]   [Full Text] [Related]  

  • 14. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).
    Majumdar SR; Lix LM; Yogendran M; Morin SN; Metge CJ; Leslie WD
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1236-42. PubMed ID: 22298803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice.
    Walker-Bone K; Wood A; Hull R; Ledingham JM; McCrae FC; Shaban R; Thomas A; Mackay K
    Clin Med (Lond); 2004; 4(5):431-6. PubMed ID: 15536872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis management among chronic glucocorticoid users: a systematic review.
    Albaum JM; Youn S; Levesque LE; Gershon AS; Cadarette SM
    J Popul Ther Clin Pharmacol; 2014; 21(3):e486-504. PubMed ID: 25527817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid-induced osteoporosis in neurology patients.
    Gallagher DA; Sturrock A
    Clin Neurol Neurosurg; 2007 Feb; 109(2):218-9. PubMed ID: 16949735
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.
    Caballero-Uribe CV; Acosta-Velez JG; Hernandez-Ruiz EA; Andrade Rodado FM; Peñuela-Epalza M
    J Clin Rheumatol; 2008 Jun; 14(3):153-5. PubMed ID: 18525434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
    Suzuki Y; Sato S
    Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factors.
    Kirigaya D; Nakayama T; Ishizaki T; Ikeda S; Satoh T
    Intern Med; 2011; 50(22):2793-800. PubMed ID: 22082891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.